1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17:1726–1733.
Article
2. Jang EJ, Lee YK, Choi HJ, et al. Osteoporotic fracture risk assessment using bone mineral density in Korean: a community-based cohort study. J Bone Metab. 2016; 23:34–39.
Article
3. New SA. Exercise, bone and nutrition. Proc Nutr Soc. 2001; 60:265–274.
4. Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001; 12:811–822.
Article
5. Tang YJ, Sheu WH, Liu PH, et al. Positive associations of bone mineral density with body mass index, physical activity, and blood triglyceride level in men over 70 years old: a TCVGHAGE study. J Bone Miner Metab. 2007; 25:54–59.
Article
6. Varenna M, Binelli L, Zucchi F, et al. Prevalence of osteoporosis by educational level in a cohort of postmenopausal women. Osteoporos Int. 1999; 9:236–241.
Article
7. Campion JM, Maricic MJ. Osteoporosis in men. Am Fam Physician. 2003; 67:1521–1526.
8. Fujimoto H, Fujimoto K, Ueda A, et al. Hypoxemia is a risk factor for bone mass loss. J Bone Miner Metab. 1999; 17:211–216.
Article
9. Karadag F, Cildag O, Yurekli Y, et al. Should COPD patients be routinely evaluated for bone mineral density? J Bone Miner Metab. 2003; 21:242–246.
10. Laudisio A, Marzetti E, Antonica L, et al. Association of left ventricular function with bone mineral density in older women: a population-based study. Calcif Tissue Int. 2008; 82:27–33.
Article
11. Sarrai M, Duroseau H, D'Augustine J, et al. Bone mass density in adults with sickle cell disease. Br J Haematol. 2007; 136:666–672.
Article
12. Gasche C. Complications of inflammatory bowel disease. Hepatogastroenterology. 2000; 47:49–56.
13. Taal MW, Masud T, Green D, et al. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant. 1999; 14:1922–1928.
Article
14. Rutten EP, Franssen FM, Spruit MA, et al. Anemia is associated with bone mineral density in chronic obstructive pulmonary disease. Copd. 2013; 10:286–292.
Article
15. Korkmaz U, Korkmaz N, Yazici S, et al. Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med. 2012; 23:154–158.
Article
16. Gurevitch O, Slavin S. The hematological etiology of osteoporosis. Med Hypotheses. 2006; 67:729–735.
Article
17. Cesari M, Pahor M, Lauretani F, et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int. 2005; 16:691–699.
Article
18. Laudisio A, Marzetti E, Pagano F, et al. Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study. Clin Rheumatol. 2009; 28:145–151.
Article
19. Kim CW, Hong S, Oh SH, et al. Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive levothyroxine therapy for differentiated thyroid carcinoma. J Bone Metab. 2015; 22:135–141.
Article
20. Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012; 33:144–151.
Article
21. Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab. 2001; 19:331–337.
Article
22. WHO Scientific Group. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968; 405:5–37.
24. Choi CD, Oh HJ, Joo IW, et al. The relationship between bone mineral density and behavioral factors in Korean adult men using data from the Korea national health and nutrition examination survey IV. Osteoporosis. 2012; 10:67–75.
25. Mun SO, Kim J, Yang YJ. Factors associated with bone mineral density in Korean postmenopausal women aged 50 years and above: using 2008-2010 Korean national health and nutrition examination survey. Korean J Community Nutr. 2013; 18:177–186.
Article
26. Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol. 2009; 201:309–320.
Article
27. Leng S, Chaves P, Koenig K, et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002; 50:1268–1271.
Article
28. Hamed EA, Mohamed NA, El-Metwally TH, et al. Iron chelation therapy in upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density. J Pediatr Hematol Oncol. 2010; 32:267–273.
Article
29. Giri N, Batista DL, Alter BP, et al. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab. 2007; 92:2624–2631.
Article
30. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12:444–454.
Article
31. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004; 104:2263–2268.
Article
32. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med. 1993; 25:385–393.
Article